The LALF32-51 peptide as component of HPV therapeutic vaccine circumvents the alum-mediated inhibition of IL-12 and promotes a Th1 response

Autor: Granadillo, Milaid, Alfonso, Alain B., Vallespi, Maribel G., Batte, Aileen, Soria, Yordanka, Brown, Enma, Limonta, Miladys, Prieto, Yayrí C., Varas, Laura, Torrens, Isis
Zdroj: In Journal of Cellular Immunotherapy March 2016 2(1):44-51
Databáze: ScienceDirect